Unusual Stem Cell Discovery Challenges Longstanding Cellular Reprogramming Theories
Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...
The American Journal of Managed Care15h
Fexagratinib in MS Shows Promise for Human Use
The investigators added that inflammation and demyelination were reduced, while axonal density oligodendrocytes, ...
Morningstar1d
Autolus Therapeutics Gets FDA Approval for Cancer Treatment
The treatment, called Aucatzyl, has been granted marketing approval for the treatment of adult patients with relapsed or refractory B-cell precursor ALL, the London biopharmaceutical company said ...
precisionmedicineonline1d
FDA Approves Autolus' CAR T-Cell Therapy Aucatzyl for B-Cell Acute Lymphoblastic Leukemia
The agency reviewed data from the FELIX trial, in which 63 percent of patients achieved a complete remission on the cell therapy at any time point.
Cure Today1d
FDA Approves CAR-T Cell Therapy for Relapsed or Refractory B-Cell ALL
The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...
Autolus wins FDA approval of Aucatzyl for acute lymphoblastic leukemia
FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...
One gene provides diagnoses for 30 patients whose condition was unexplained for years
An international team of researchers has provided a genetic diagnosis for 30 individuals whose condition was undiagnosed for ...
Business Insider1d
FDA approves obecabtagene autoleucel for certain type of ALL
for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, or ALL. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try ...
Hosted on MSN2d
New CAR T-Cell Therapy Approved for Leukemia
The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...
sicklecellanemianews2d
BEAM-101 gene-editing stem cell therapy shows promise in SCD
BEAM-101, a gene-editing stem cell therapy, showed early signs of efficacy among the first treated sickle cell patients in a ...
When the Brain Cells in the Petri Dish Stare Back
Scientists have created brain ‘organoids’ that may be showing early signs of sentience. Should that give researchers pause?
pv magazine International3d
Perovskite-silicon tandem solar cell based on copper(I) thiocyanate achieves 31.46% efficiency
Chinese research team has fabricated a perovskite-silicon tandem solar cell without a hole transport layer (HTL) in the ...